tiprankstipranks
Advertisement
Advertisement
Daxor issues update in Letter to Shareholders
PremiumThe FlyDaxor issues update in Letter to Shareholders
3M ago
Daxor reports NAV per share of $9.07
Premium
The Fly
Daxor reports NAV per share of $9.07
3M ago
Daxor continues strategic expansion, opens new BVA program in Tennessee
Premium
The Fly
Daxor continues strategic expansion, opens new BVA program in Tennessee
4M ago
Daxor Releases Updated Investor Presentation to Public Markets
PremiumCompany AnnouncementsDaxor Releases Updated Investor Presentation to Public Markets
5M ago
Daxor announces expansion of its BVA platform into three new facilities
Premium
The Fly
Daxor announces expansion of its BVA platform into three new facilities
7M ago
Daxor to exhibit at the MedAxiom CV Transforum Fall’25 Conference
Premium
The Fly
Daxor to exhibit at the MedAxiom CV Transforum Fall’25 Conference
8M ago
Daxor’s FDA Clearance and Advancements Propel Buy Rating Amidst Growth Potential
PremiumRatingsDaxor’s FDA Clearance and Advancements Propel Buy Rating Amidst Growth Potential
10M ago
Why Is Daxor Stock (DXR) Up 20% Today?
Premium
Market News
Why Is Daxor Stock (DXR) Up 20% Today?
10M ago
Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories
Premium
Market News
Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100